These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9433037)

  • 41. How reliable is medical malpractice law? A review of "Medical Malpractice and the American Jury: confronting the myths about jury incompetence, deep pockets, and outrageous damage awards" by Neil Vidmar.
    O'Connell J; Pohl C
    J Law Health; 1997-1998; 12(2):359-79. PubMed ID: 10539297
    [No Abstract]   [Full Text] [Related]  

  • 42. The constitutional right to be free from double jeopardy: a new bastion against multiple punishments.
    Schneider DC
    Med Staff Couns; 1991; 5(2):33-8. PubMed ID: 10110107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacist's duty to warn.
    Cacciatore GG
    Am J Hosp Pharm; 1994 Nov; 51(22):2824-6. PubMed ID: 7856608
    [No Abstract]   [Full Text] [Related]  

  • 44. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm.
    Furrow BR
    Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162
    [No Abstract]   [Full Text] [Related]  

  • 45. The doctor/patient relationship and immunity from malpractice.
    Spector RA
    J La State Med Soc; 2001 Oct; 153(10):501-3. PubMed ID: 18350709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 47. Mediation and medical malpractice: the need to understand why patients sue and a proposal for a specific model of mediation.
    Meruelo NC
    J Leg Med; 2008; 29(3):285-306. PubMed ID: 18726757
    [No Abstract]   [Full Text] [Related]  

  • 48. Is liability possible for forensic psychiatrists?
    Weinstock R; Garrick T
    Bull Am Acad Psychiatry Law; 1995; 23(2):183-93. PubMed ID: 8605402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Court narrows landmark liability ruling.
    Kazon PM
    Bus Health; 1990 Dec; 8(12):58-9. PubMed ID: 10107906
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prevention of thrombosis with reference to legal liability and malpractice].
    Ulsenheimer K
    Zentralbl Chir; 1991; 116(18):1087-92. PubMed ID: 1763579
    [No Abstract]   [Full Text] [Related]  

  • 51. Liability relating to formularies and drug utilization management.
    Elden DL
    AAPPO J; 1991; 1(2):33-7, 43-6. PubMed ID: 10148900
    [No Abstract]   [Full Text] [Related]  

  • 52. Controlling defensive medical practices and costs through state health policy reform.
    Jones WA; Johnson JA; Williams SP
    J Health Hum Serv Adm; 1996; 19(2):163-81. PubMed ID: 10166071
    [No Abstract]   [Full Text] [Related]  

  • 53. [The physician and the law. Responsibility after a liability incident--what can, what should be done from the legal viewpoint?].
    Ulsenheimer K; Bock RW
    Chirurg; 1991 Nov; 62(11):suppl 193-6. PubMed ID: 1769247
    [No Abstract]   [Full Text] [Related]  

  • 54. Groping for the reins: ERISA, HMO malpractice, and enterprise liability.
    Kilcullen JK
    Am J Law Med; 1996; 22(1):7-50. PubMed ID: 8819595
    [No Abstract]   [Full Text] [Related]  

  • 55. Physician dispensing of drugs. Usurping the pharmacist's role.
    Trytek KA
    J Leg Med; 1988 Dec; 9(4):637-61. PubMed ID: 3244010
    [No Abstract]   [Full Text] [Related]  

  • 56. Liability surcharges in physician offices.
    Rohack JJ
    J Okla State Med Assoc; 2005 Oct; 98(10):494-6. PubMed ID: 16296208
    [No Abstract]   [Full Text] [Related]  

  • 57. Riff v. Morgan Pharmacy. A legal mandate for patient-oriented pharmacy practice.
    Brushwood DB; Simonsmeier LM
    Am Pharm; 1987 Mar; NS27(3):68-9. PubMed ID: 3565255
    [No Abstract]   [Full Text] [Related]  

  • 58. Liability implications of utilization review as a cost containment mechanism.
    Schessler CE
    J Contemp Health Law Policy; 1992; 8():379-406. PubMed ID: 10118988
    [No Abstract]   [Full Text] [Related]  

  • 59. Careful telemedicine planning limits costly liability exposure.
    Edelstein SA
    Healthc Financ Manage; 1999 Dec; 53(12):63-6, 68-9. PubMed ID: 11066698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The learned intermediary doctrine and prescription wheelchairs.
    Coughlan SG; Kirby RL; Christie M
    Health Law Can; 1995; 15(3):65-71. PubMed ID: 10141077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.